Pharmaceutical Technology on MSN
Inductive Bio gains $21m ARPA-H funds for drug prediction models
The ARPA-H CATALYST programme aims to transform preclinical drug safety prediction using human-based models.
Researchers can now order their mutation of choice in bit.bio’s opti-ox TM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated ...
The PharmTech Group spoke with BIOVECTRA's director of Business Development, Nucleic Acid Modalities, Jessica Madigan, about the concept of flexibility in outsourcing and the 2024 BIO Convention.
MINNEAPOLIS--(BUSINESS WIRE)--A recently published paper in Translational Lung Cancer Research details encouraging results from nonclinical studies conducted with Humanetics Corporation’s (Humanetics) ...
Accurate cancer models are integral to the success of preclinical research yet have proven elusive. Mindy Goldsborough (ATCC, VA, USA) discusses the ongoing efforts to develop improved in vitro models ...
BioTechniques Digital Editor, Tristan Free, catches up with Guohao Dai, Associate Professor of Bioengineering at Northeastern University (MA, USA), to discuss his recent work making improvements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback